Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MERUS LABS INTERNATIONAL INC T.MSL

Healthcare Drug Manufacturers - Specialty & Generic
"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."


TSX:MSL - Post by User

MERUS LABS INTERNATIONAL INC
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2019)
•••
Post by lscfaon Aug 15, 2016 12:09pm
201 Views
Post# 25142421

Kneejerk reaction

Kneejerk reaction Idiot sellers don't dig past the headline numbers....stockwatch says MSL loses $5.1 million in Q3 but the economic reality is MSL generated $8 million in operating cash flow.......



Date ET Symbol Price Type Headline
2016-08-15 08:07 MSL 1.60 SEDAR Interim Financial Statements SEDAR Interim Financial Statements
2016-08-15 08:07 MSL 1.60 SEDAR MD & A SEDAR MD & A
2016-08-15 08:01 MSL 1.60 News Release Merus Labs International loses $5.1-million in Q3 2016

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities